Quality control in cervical cancer screening in the UK should target false negatives
This article was originally published in Clinica
The number of false negative results detected under the UK cervical screening programme could be reduced if the focus of quality assurance systems were changed, says a new study. An investigation into why false negatives occur and how they could be reduced has found that there are quantitative differences between false negatives and true positives, according to a study in the latest issue of the Journal of Clinical Pathology (1999;52:358-62).
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.